A broad array of cell surface and signaling proteins is involved in tubulogenesis [43], and could explain why the perivascular invasion is more important in vascular endothelial growth factor (VEGF)-deficient glioblastoma cells and brain tumor xenografts treated with anti-VEGF blocking antibodies such as bevacizumab [44, 45]. Here, VEGFA is linked to brain neoplasm.